Clinical Trials Browser

Phase 3 × Injections × Plasma cell × Clear all

NCT05020236 2026-02-02

MAGNETISMM-5

Phase 3 Recruiting

Multiple Myeloma

NCT04288765 2021-07-09

Carfilzomib, Daratumumab, Lenalidomide and Dexamethasone as First Line Treatment in Multiple Myeloma

Phase 3 Withdrawn

Multiple Myeloma